Evidence map›Paper›PMID 35494301›Full record

ArticleArthroscopy, sports medicine, and rehabilitation2022

Arthroscopic Bankart and Remplissage for Anteroinferior Instability With Subcritical Bone Loss Has a Low Recurrence Rate.

Shirish Pathak, Murtaza J Haidermota, Vimal Kumar K H, Parag Sancheti

Open access · goldAbstract read
In one paragraph

Article in Arthroscopy, sports medicine, and rehabilitation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Shirish PathakDepartment of Shoulder and Sports Medicine, Deenanath Mangeshkar Hospital and Research Centre, Maharashtra, India.
Murtaza J HaidermotaDepartment of Orthopaedics, Sancheti Institute for Orthopaedics and Rehabilitation, Shivajinagar, Maharashtra, India.
Vimal Kumar K HDepartment of Shoulder and Sports Medicine, Deenanath Mangeshkar Hospital and Research Centre, Maharashtra, India.
Parag SanchetiDepartment of Orthopaedics, Sancheti Institute for Orthopaedics and Rehabilitation, Shivajinagar, Maharashtra, India.
Deenanath Mangeshkar Hospital and Research Center · INSancheti Institute For Orthopaedics & Rehabilitation · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To demonstrate whether arthroscopic remplissage can achieve good outcomes without significantly impairing shoulder function. Methods: Consecutive patients with recurrent anterior glenohumeral dislocation, glenoid bone loss <20%, and engaging Hill-Sachs lesion who were operated with arthroscopic Bankart repair and remplissage between 2013 and 2016 were identified. Patients were evaluated clinically for shoulder instability, range of motion, and scored as per Oxford Shoulder Instability Score and University of California at Los Angeles score. The data were analyzed with the paired Results: Twenty-four patients were included in the study. The average age of the patients was 30 years (range, 18-47 years), with 91.67% (n = 22) male patients and 8.33% (n = 2) female patients. The range of motion at follow-up was comparable with the normal side, with loss of external rotation of 3.33° (n = 24). Significant improvement was observed in the Oxford Shoulder Instability Score (21.95 vs 41.29, Conclusions: Arthroscopic Bankart repair with the remplissage procedure helps to re-establish stability and achieve good shoulder outcomes for patients with recurrent anterior glenohumeral dislocation and an engaging Hill-Sachs lesion and without significant glenoid bone loss. Level of Evidence: Level IV, therapeutic.

Identifiers

PMID35494301
PMCPMC9042916
OpenAlexW4210381308

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.